The mTORC1 pathway intersects with key mitogenic signals driving tumor development, such as mutations of PI3K, EGFR, K-ras, or loss of phosphatase and tensin homolog (PTEN), which can also lead to hyperactivation of mTORC1 in numerous human cancers42. The gene discussed is KRAS; the disease is neoplasm.